Philip Morris
Inappropriate and Appropriate Selection of 'peers' in Grant Review. Public Bias and Public Policy
Fields
- Author
- Bero, L.
- Glantz, S.A.
- Rennie, D.
- Glantz, S.A.
- Type
- ABST, ABSTRACT
- Attachment
- 2048252199/2048252525
- 2048252387/2048252418
- Area
- WORLDWIDE REG AFFAIRS/LIBRARY
- Site
- N403
- Request
- Stmn/R1-048
- Named Organization
- NCI, Natl Cancer Inst
- Natl Heart Lung + Blood Inst
- Behavioral Medicine Study Wsection
- Cardiovascular Study Section
- Epa, Environmental Protection Agency
- Natl Heart Lung + Blood Inst
- Document File
- 2048252198/2048252525/Bero Barnes (Ciar)
- Master ID
- 2048252379/2524
Related Documents:- 2048252379 Requested Papers
- 2048252380
- 2048252381-2386 Evaluating the Quality of Articles Published in Journal Supplements Compared with the Quality of Those Published in the Parent Journal
- 2048252387 Preventing Alcohol and Substance Abuse in Minority Youth Recent Results From Asap Training and Demonstration Programs. Prevention Works: Trends in Drug Abuse Education 760000 - 900000. Long Term Prevention of Tobacco Use Among Junior High School Students Through Classroom and Telephone Interventions. Misuse of the Scientific Literature by the Tobacco Industry.
- 2048252388-2391 Appendix Coding Definitions for Article Content
- 2048252392-2402 Tobacco Industry Response to A Risk Assessment of Environmental Tobacco Smoke
- 2048252403 Quit and Win Wales: An Evaluation of the 900000 Pilot Content
- 2048252407-2414 Sponsored Symposia on Environmental Tobacco Smoke
- 2048252415-2418 Publication Bias and Public Health Policy on Environmental Tobacco Smoke
- 2048252419
- 2048252420-2421 Taking Money From the Devil
- 2048252422
- 2048252423-2429 the Publication of Sponsored Symposiums in Medical Journals
- 2048252430-2431 Tobacco Industry Funding of Biomedical Research
- 2048252432
- 2048252433-2438 Ethical Issues Relating to the Conduct and Interpretation of Epidemiologic Research in Private Industry
- 2048252439
- 2048252440-2445 Independent Investigators and for-Profit Companies Guidelines for Biomedical Scientists Considering Funding by Industry
- 2048252446
- 2048252447-2450 Source of Funding and Outcome of Clinical Trials
- 2048252451
- 2048252452-2456 Sounding Board Avoiding Bias in the Conduct and Reporting of Cost-Effectiveness Research Sponsored by Pharmaceutical Companies
- 2048252457
- 2048252458-2465 Uniform Requirements for Manuscripts Submitted to Biomedical Journals
- 2048252466
- 2048252467 Editorial Conflict of Interest Policy
- 2048252468
- 2048252469-2471 New Requirements for Authors: Signed Statements of Authorship Responsibility and Financial Disclosure
- 2048252472
- 2048252473-2475 Commentary Conflict of Interest and Scientific Publicati
- 2048252476
- 2048252477-2479 Dealing with Conflicts of Interest
- 2048252480
- 2048252481-2482 New 'information for Authors' - and Readers
- 2048252483-2491 A Study of Manufacturer - Supported Trials of Nonsteroidal Anti-Inflammatory Drugs in the Treatment of Arthritis Reporting and Documentation of Efficacy and Toxicity
- 2048252492
- 2048252493-2497 Sounding Board Physicians' Conflicts of Interest the Limitations of Disclosure
- 2048252498
- 2048252499-2501 Commentary Conflict of Interest the New Mccarthyism in Science
- 2048252502
- 2048252503-2505 Researchers Try to Separate Smoking Fact From Fiction
- 2048252506-2507
- 2048252508-2513 Influence of Design Characteristics on the Outcome of Retrospective Cohort Studies
- 2048252514
- 2048252515-2519 Conflict of Interest Dilemmas in Biomedical Research
- 2048252520
- 2048252521-2524 When Researchers Accept Funding From the Tobacco Industry, Do Ethics Go Up in Smoke? the Research Game.
- Author (Organization)
- 2nd Intl Congress on Peer Review in Biom
- Amed, American Medical Association
- Inst for Health Policy Studies
- Univ of Ca San Francisco
- Amed, American Medical Association
- Litigation
- Stmn/Produced
- Characteristic
- MARG, MARGINALIA
- MISS, MISSING PAGES
- Date Loaded
- 05 Jun 1998
- UCSF Legacy ID
- efq92e00
Document Images
Second International Congress on Peer Review
in Biomedical Publication
Sponsored by the American Medical Association

1
The Second Peer Review Congress I Abstracts
/Inappropriate and Appropriate
Selection of 'Peers' in Grant Review
*Stanton A. Glantz
Division of Cardiology, Box 0124, University of California. San
Francisco. CA 94143-0124
Objective: To assess the California Tobacco Related Disease
Research Program (TRDRP) Behaviorial and Public Health
Research on Tobacco Study Section members as "peers" to
review tobacco policy research.
Design: MEDLINE was searched for the years 1989 through
1993 with the use of the key word tobacco for TRDRP
reviewers. The National Heart. Lung and Blood Institute
(NHLBI) Cardiovascular Study Section, which reviews my
NHLBI grant on ventricular function, was searched as a
control using the key word heart.
Results: Six of 18 TRDRP reviewers (33%) had no citations.
The median number of citations was two (interquartile range,
zero through four). I had seven publications indexed to
"tobacco"; only one member (5%) had more than seven
publications indexed on "tobacco." The members' "tobacco"
publications concentrated on well-controlled experimental
interventions on smoking cessation and prevention strategies.
Only one member had primary expertise in tobacco policy
research. All 31 (100%) of the NHLBI reviewers had "heart"
publications. The median number of citations was nine
(interquartile range, seven through 19). I had 11 publications
indexed to "heart"; 13 members (42%) had more than 11
publications. Five members had a primary interest in the
subject of my NHLBI application.
Conclusions: Members' professional interests play a critical
role in the level of interest and enthusiasm they will have for
a proposal, which directly affects the priority score. The
TRDRP's primary focus is experimental intervention; the
single member on tobacco control does not overcome the
biases intrinsic in this membership. A similar situation exists
at the National Cancer Institute, where the Behavioral
Medicine Study Section has not funded one of the last 41
applications for tobacco control research. The membership of
these review committees has effectively precluded research
on tobacco control policy.
Statistics and Peer Review
Do We Need Structured Reporting
of Randomized Controlled Trials?
*David Moher, Corrine S. Dulbera, and George A. Wells
Clinical Epidemiology Unit, Loeb Medical Research Institute, Ottawa
Civic Hospital, 1053 Carling Ave, Ottawa, Ontario, Canada K1Y 4E9
Objective: To examine whether there has been a change in
the reporting of statistical power and sample size calculations
in published negative randomized controlled trials (RCTs)
during the last 15 years.
Design: A structured data collection form and guidelines to
12
classify a trial as negative and to determine primary outcomes
were developed. All RCTs published in three leading general
medical journals published in 1975, 1980, 1985, and 1990
were reviewed.
Results: There were 102 negative RCTs published during this
15-year review. Of these. only 33 (32%) reported calculating
sample size. Although this number is small, the situation has
improved over time, from 0% in 1975 to 43% in 1990. Less
than half of the trials reported the control group event rate
(45%). Eighteen percent reported whether the alpha was one
or two tailed, and no trial reported the statistic on which
sample size calculations were based. Only 20 trials made any
kind of statement of the clinical sigrtificance of the results
with respect to the observed differences.
Conclusions: There has been a considerable increase in the
number of RCTs published durin= the period of this review.
Our results indicate that there is still room for improvement in
the quality of reporting of many statistical issues. Structur.J
reporting of pertinent information in RCTs mi=ht improve
communication in the same way as have structured abstracts.
Assessing the Quality
of Randomization From Reports
of Controlled Trials Published
in Journals of Obstetrics and
Gynecology
Kenneth F. Schulz.' *lain Chalmers.' David A. Grimes.= and
Douglas G. Altman'
'UK Cochrane Centre. Summenown Pavilion. Middle Way. Oxford OX2
7LG. England: =Depanment of Obstetrics. Gynecology and Reproductive
Sciences. University of California. San Francisco: and 'Medical Statistics
Laboratory. Imperial Cancer Research Fund. London. England
Objective: To assess the extent to which reports of controlled
provide details
trials in journals of obstetrics and gynecology
of the way in which trial participants were allocated to
treatment comparison groups.
Design: Survey of all reports of parallel group trials (in which
allocation was stated to have been randomized) published in
the 1990 and 1991 volumes of four joumals of obstetrics and
gynecolog
gy.
Results: Of 206 reports identified, only 32% gave an
acceptable account of the method used to generate random
numbers, and only 23% contained information showing that
steps had been taken to conceal assignment until the point of
treatment allocation. In 125 reports in which hypothesis tests
were used to compare baseline characteristics, only 2% were
statistically significant at the 5% level. In 96 reports of trials
usins unblocked randomization, the differences in sample
sizes between treatment and control groups were much
smaller than would be expected by chance (P<.0001).
Conclusions: Proper randomization is required to generate
unbiased comparison groups in clinical trials. Only 10% of
the reports of trials published in a'sample of obstetrics and
~ynecoloQy journals described proper methods of randomiza-
tion. Additional analyses suggest that there may have been
both selective reporting of baseline comparisons and non-
random manipulation of comparison groups by investigators.

The Second Peer Review Congress / Abstracts
scientific review article were cited significantly less often
than other papers by Slutsky.
Conclusions: Scientists did not suspect that Slutsky's papers
contained fabrications until news of Slutsky's misconduct
became public. Afterward, scientists looked to Slutsky's
academic institution for guidance as to which articles were
tainted. Academic institutions can play a significant role in
correcting the scientific literature by thoroughly investigating
suspected cases of fraud and disclosing their findings.
Duplicate Publication of Original
Articles in and From the Nederlands
Tijdschrift voor Geneeskunde (Dutch
Journal of Medicine)
Hans Barnard and *:jnn A. Overbeke
Nederlands Tijdschrift voor Geneeskunde. PO Box 75971. 1070 AZ
Amsterdam. the Netherlands
Objective: To determine the numbers of correct and incorrect
duplicate publications of original articles in the Nederlands
Tijdschrift voor Geneeskunde (Dutch Journal of Medicine)
based on the statement on duplicate publication by the
International Committee of Medical Journal Editors (ICMJE).
Design: Retrospective bibliometric study followed by
interviews. Of the first and second authors of 172 original
articles (al195 articles from the first half of 1990 and all 77
articles from the first half of 1992). all biomedical publica-
tions havin- the same purport published in 1990 through
1992 were looked up. The authors were subsequently
approached by telephone to find out the background of these
duplicate publications.
Results: For two articles the corresponding articles were not
found. Of the remainina 94 articles from the first half of 1990,
11 (12%) proved to have been published again without this
fact being mentioned in a footnote (for which omission the
journals were responsible in four cases and the authors in
seven cases). Of the remaining 76 articles from the first half
of 1992, 12 were found to have been published previously,
five in accordance with and seven against the IC.'uL1E
statement. Duplicate publication against the statement was
attributed to incorrect interpretation of the ICMJE statement
by the authors.
Conclusions: Of the original articles published in the
Nederlands Tijdschrift voor Geneeskunde. a minimum of
14% are being or have already been published elsewhere,
11% without this fact beina stated according to the ICMJE
statement on duplicate publication.
Bias and Peer Review
Publication Bias and Public Policy
*Lisa Bero and Drummond Rennie
Institute for Health Policy Studies, University of California. San
Francisco, 1388 Sutter St. I 1 th Floor, San Francisco. CA 94109
Objective: To examine the tobacco industry's claim that
publication bias makes risk assessments of environmental
tobacco smoke (ETS ) invalid. Public health policies
regulating exposure to hazardous compounds, such as ETS,
are often based on risk assessments. The tobacco industry has
argued, most recently in a lawsuit against the the US
Environmental Protection Agency (EPA), that the EPA's risk
assessment of ETS, which concluded that ETS is a cause of
lung cancer and respiratory disorders, is invalid. The industry
claims that the meta-analysis conducted by the EPA was
flawed because publication bias against "negative" studies
resulted in exclusion of negative studies from the
meta-analysis.
Design: To determine if negative studies on ETS are
published, the numbers of articles that supported ("positive
studies") or refuted ("negative studies") the hypothesis that
ETS exposure is associated with adverse health effects were
assessed. All articles that tested this hypothesis were selected
from the peer-reviewed medical literature and tobacco
industry-sponsored symposia proceedings. Articles were
identified by a computerized search of the medical literature
supplemented with material obtained from the tobacco
industry.
Results: Eighty-two percent (40/49) of the peer-reviewed
articles were positive, compared with 37% (24/65) of
symposia articles (P= .0001). Ninety-four percent (46/49) of
the peer-reviewed articles contained a "Methods" section.
compared with 43% (28/65) of symposia articles (P=.0001).
Conclusions: These findings raise the policy question of
whether negative studies should automatically be included in
meta-analyses. We recommend that the quality of the studies,
their sponsorship, and the review process to which they have
been subjected be carefully evaluated.
Effect of Institutional Prestige
on Reviewers' Recommendations
and Editorial Decisions
*Joseph M. Garfunkel. Harvey J. Hamrick, Edward E. Lawson, and
Martin H. Ulshen
Journal of Pediatrics. CBN 7230. Medical School Wing C. University of
North Carolina, Chapel Hill. NC 27599-7230
Objective: To determine whether manuscripts from institu-
tions with greater "prestige" are more likely to be
recommended for publication by reviewers and to be accepted
for publication.
»
